Trials / Completed
CompletedNCT05697315
Erector Spinae Plane Block for Postoperative Pain Management
The Effect of Erector Spinae Block for Postoperative Pain Management Cesarean Delivery Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Kahramanmaras Sutcu Imam University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Erector spinae plane (ESP) block is an interfacial plane block with visceral and somatic analgesic activity at paraspinal muscles. This study aims to examine the postoperative analgesic efficacy of ESP block after cesarean section (CS) with Pfannenstiel incision under spinal anesthesia.
Detailed description
The study included 54 patients with mild systemic disease (ASA II patients) who would undergo elective CS under spinal anesthesia. They were randomly divided into an ESP block group (Group E) and a control group (Group C). After the surgery, Group E patients underwent ultrasound-guided bilateral ESP block with 20 ml of 0.25% bupivacaine at the lateral decubitus position, while Group C received no intervention. Patients in both groups received parenteral patient-controlled analgesia. The patients' post-operative 24-hour opioid consumption, regular Visual Analogue Scale (VAS) measurements, and need for rescue analgesics were evaluated. Statistical analysis was performed using SPSS 21 program. Demographic and other data were assessed using independent samples t-test, Mann-Whitney U test, and Chi-square analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Control | No block was performed |
| PROCEDURE | Erector spinae plane block | Erector spinae plane block was performed, tramadol was administered with patient-controlled analgesia (PCA) and all patients were followed in the ward. |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2022-04-01
- Completion
- 2022-04-01
- First posted
- 2023-01-25
- Last updated
- 2023-01-25
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05697315. Inclusion in this directory is not an endorsement.